End-of-day quote
Shanghai S.E.
06:00:00 2024-05-05 pm EDT
|
5-day change
|
1st Jan Change
|
17.08
CNY
|
+2.95%
|
|
+2.46%
|
+15.64%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
69,740
|
85,800
|
127,307
|
88,278
|
108,025
|
124,920
|
-
|
-
|
Enterprise Value (EV)
1 |
69,740
|
85,800
|
127,307
|
88,278
|
108,025
|
124,920
|
124,920
|
124,920
|
P/E ratio
|
18.3
x
|
18.6
x
|
17.9
x
|
14
x
|
19.2
x
|
14.5
x
|
8.64
x
|
8.45
x
|
Yield
|
-
|
2.39%
|
1.85%
|
1.16%
|
1.9%
|
2.74%
|
3.15%
|
4.52%
|
Capitalization / Revenue
|
5.14
x
|
5.39
x
|
5.46
x
|
3.11
x
|
3.71
x
|
3.19
x
|
2.19
x
|
2.04
x
|
EV / Revenue
|
5.14
x
|
5.39
x
|
5.46
x
|
3.11
x
|
3.71
x
|
3.19
x
|
2.19
x
|
2.04
x
|
EV / EBITDA
|
-
|
-
|
13.1
x
|
9.62
x
|
12.6
x
|
9.45
x
|
6.25
x
|
6.36
x
|
EV / FCF
|
-
|
-
|
113
x
|
-26.3
x
|
-26.2
x
|
47.7
x
|
6.99
x
|
7.97
x
|
FCF Yield
|
-
|
-
|
0.89%
|
-3.8%
|
-3.82%
|
2.1%
|
14.3%
|
12.5%
|
Price to Book
|
2.99
x
|
3.31
x
|
4.15
x
|
2.61
x
|
2.81
x
|
2.69
x
|
2.08
x
|
1.84
x
|
Nbr of stocks (in thousands)
|
7,333,360
|
7,333,360
|
7,333,360
|
7,313,816
|
7,313,816
|
7,313,816
|
-
|
-
|
Reference price
2 |
9.510
|
11.70
|
17.36
|
12.07
|
14.77
|
16.59
|
16.59
|
16.59
|
Announcement Date
|
3/15/20
|
3/4/21
|
3/8/22
|
3/9/23
|
3/21/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
13,568
|
15,928
|
23,300
|
28,430
|
29,136
|
39,152
|
57,030
|
61,216
|
EBITDA
1 |
-
|
-
|
9,738
|
9,174
|
8,600
|
13,216
|
19,980
|
19,639
|
EBIT
1 |
4,632
|
5,536
|
8,421
|
7,720
|
6,786
|
10,001
|
16,622
|
17,096
|
Operating Margin
|
34.14%
|
34.76%
|
36.14%
|
27.15%
|
23.29%
|
25.54%
|
29.15%
|
27.93%
|
Earnings before Tax (EBT)
1 |
-
|
5,249
|
8,121
|
7,307
|
6,467
|
9,659
|
16,310
|
16,744
|
Net income
1 |
3,802
|
4,623
|
7,070
|
6,303
|
5,651
|
8,377
|
14,080
|
14,418
|
Net margin
|
28.02%
|
29.02%
|
30.35%
|
22.17%
|
19.39%
|
21.4%
|
24.69%
|
23.55%
|
EPS
2 |
0.5184
|
0.6300
|
0.9700
|
0.8600
|
0.7700
|
1.143
|
1.921
|
1.964
|
Free Cash Flow
1 |
-
|
-
|
1,131
|
-3,351
|
-4,129
|
2,619
|
17,876
|
15,669
|
FCF margin
|
-
|
-
|
4.85%
|
-11.79%
|
-14.17%
|
6.69%
|
31.35%
|
25.6%
|
FCF Conversion (EBITDA)
|
-
|
-
|
11.61%
|
-
|
-
|
19.82%
|
89.47%
|
79.79%
|
FCF Conversion (Net income)
|
-
|
-
|
15.99%
|
-
|
-
|
31.27%
|
126.96%
|
108.68%
|
Dividend per Share
2 |
-
|
0.2800
|
0.3210
|
0.1400
|
0.2800
|
0.4550
|
0.5220
|
0.7500
|
Announcement Date
|
3/15/20
|
3/4/21
|
3/8/22
|
3/9/23
|
3/21/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-
|
1,131
|
-3,351
|
-4,129
|
2,619
|
17,876
|
15,669
|
ROE (net income / shareholders' equity)
|
19.3%
|
19%
|
25%
|
19.6%
|
15.7%
|
18.4%
|
24.5%
|
21.9%
|
ROA (Net income/ Total Assets)
|
12.6%
|
12.9%
|
17.1%
|
12.4%
|
8.75%
|
11.5%
|
15%
|
14.5%
|
Assets
1 |
30,061
|
35,700
|
41,239
|
50,976
|
64,604
|
72,947
|
93,825
|
99,435
|
Book Value Per Share
2 |
3.180
|
3.530
|
4.180
|
4.620
|
5.260
|
6.170
|
7.980
|
9.020
|
Cash Flow per Share
2 |
0.4900
|
0.7100
|
0.8900
|
0.9000
|
1.190
|
1.730
|
2.740
|
2.330
|
Capex
1 |
4,541
|
2,574
|
5,357
|
9,977
|
12,822
|
5,314
|
4,633
|
3,827
|
Capex / Sales
|
33.46%
|
16.16%
|
22.99%
|
35.09%
|
44.01%
|
13.57%
|
8.12%
|
6.25%
|
Announcement Date
|
3/15/20
|
3/4/21
|
3/8/22
|
3/9/23
|
3/21/24
|
-
|
-
|
-
|
Last Close Price
16.59
CNY Average target price
23.4
CNY Spread / Average Target +41.05% Consensus |
1st Jan change
|
Capi.
|
---|
| +12.32% | 16.77B | | +3.30% | 102B | | -1.92% | 65.53B | | +47.62% | 41.76B | | +15.99% | 38.66B | | +5.47% | 32.28B | | +10.07% | 19.57B | | +17.69% | 15.08B | | +8.31% | 14.83B | | -14.59% | 13.95B |
Other Commodity Chemicals
|